One Hour Preoperative Gatifloxacin - Full Text View

Home Search Study Topics Glossary

One Hour Preoperative Gatifloxacin

The recruitment status of this study is unknown because the information has not been verified recently.

Verified January 2007 by Stanford University. Recruitment status was Recruiting

First Received on July 5, 2006. Last Updated on May 31, 2011 History of Changes

Sponsor:	Stanford University
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00350363

Purpose

Comparison of 1 day versus 1 hour application of topical Zymar.

Condition	Intervention	Phase
Ophthalmic Surgery	Drug: Zymar	Phase IV

Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: Single Blind
Official Title:	One Hour Preoperative Gatifloxacin

Resource links provided by NLM:

Drug Information available for: Gatifloxacin

U.S. FDA Resources

Further study details as provided by Stanford University:

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00350363

Contacts

Contact: Christopher Ta, MD

650-725-6995

Locations

United States, California
Stanford	Recruiting
Stanford, California, United States, 94304

Sponsors and Collaborators

Stanford University

Investigators

Principal Investigator:

Christopher Ta, MD

Stanford University

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00350363 History of Changes
Other Study ID Numbers:	5004
Study First Received:	July 5, 2006
Last Updated:	May 31, 2011
Health Authority:	United States: Institutional Review Board

Additional relevant MeSH terms:

Gatifloxacin
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on February 12, 2012